HA1C

CHICAGO (Reuters) - Diabetics who take insulin plus a diabetes pill have a lower risk of developing Alzheimer’s disease than diabetics who take insulin alone, U.S.
Go to Source

NEW YORK (Reuters Health) - People with diabetes are at increased risk of developing tuberculosis (TB), according to a review of published studies.
Go to Source

BETHESDA, Maryland (Reuters) - Researchers working on an artificial pancreas believe they are just a few years away from a nearly carefree way for people with diabetes to monitor blood and inject insulin as needed.
Go to Source

Women who receive a diagnosis of diabetes before they become pregnant are three to four times more likely to have a child with one or even multiple birth defects than a mother who is not diabetic, according to a study by the Centers for Disease Control and Prevention (CDC), released in the American Journal of Obstetrics and Gynecology.
Go to Source

Those who drink in excess of the U.S. Dietary Guidelines (i.e., men who usually drink more than two drinks per day or women who usually drink more than one drink per day) or those who binge drink are at increased risk for the metabolic syndrome, according to a new study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
Go to Source

Pregnant women with diabetes are three to four times more likely to give birth to an infant with a birth defect than other pregnant women, according to a CDC study scheduled to be published in the American Journal of Obstetrics and Gynecology, the AP/San Jose Mercury News reports.
Go to Source

A healthy diet and exercise program are part of the prescription for people with type 2 diabetes, but two new research reviews suggest they can also help to prevent the disease. A third review finds that patients from ethnic minorities do better with diabetes education that takes their language and culture into account.
Go to Source

A blood test currently used as the gold standard for monitoring people already under care for diabetes may have far wider use in identifying millions with undetected diabetes, a team led by a Johns Hopkins physician suggests.
Go to Source

Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.
Go to Source

AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced top-line results from its ANDES Phase 3 clinical trial of AGI-1067 (succinobucol) for the treatment of Type 2 diabetes demonstrating that both doses (75mg and 150mg) of AGI-1067 met the primary efficacy endpoint of the reduction in glycosylated hemoglobin (A1c) versus placebo at the end of the study’s six month dosing regimen.
Go to Source